InterStim Therapy System Verify Evaluation System
Medtronic Neuromodulation · Decision date Sep 14, 2026
What did the FDA decide?
The FDA record lists PMA supplement P970004/S458 for the InterStim Therapy System under applicant Medtronic Neuromodulation, device category stimulator, electrical, implantable, for incontinence, with product code EZW. It is a 30-Day Notice, and its stated purpose is the addition of a manufacturing verification step for the WR9220A and P720R1 wireless rechargers. The record gives no further description of how that verification step is performed or what it verifies.
The supplement identifier ties this notice to original PMA P970004, but a supplement is not a new approval of the whole system, and a manufacturing notice filed under a process-change reason is not an original PMA. The record does not state whether the verification step affects device performance, safety or clinical effectiveness, and the notice's reported purpose is not independent proof of those outcomes.
The supplied fields also lack details on the recharger models themselves and on any manufacturing sites or suppliers involved, so the scope of the change remains limited to the wording of the statement.
FDA approval order statement
the addition of a manufacturing verification step for the WR9220A and P720R1 wireless rechargers
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 14, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P970004/S458
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic Neuromodulation
- Product code
- EZW
- Decision code
- OK30
- Decision date
- Sep 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, electrical, implantable, for incontinence.
- Applicant
- Medtronic Neuromodulation
- Product code
- EZW
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P970004. Subsequent supplements may change the device or its indications.
FDA decision timeline
P970004 · Original PMA
MEDTRONIC INTERSTIM THERAPY SYSTEM FOR URINARY CONTROL
P970004/S458 received
Application receipt date recorded by FDA.
P970004/S458 · FDA decision
30-Day Notice
P970004/S457 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S459 · Related supplement
InterStim Therapy System, Verify Evaluation System
P970004/S460 · Related supplement
InterStim Therapy System, Verify Evaluation System (SNS Urinary Neurostimulator 97800), (SNS Urinary Neurostimulator I
Timeline entries are records held by MedtechLedger for P970004. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P970004
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Neuromodulation | PMA approval | Sep 29, 1997 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 6, 2026 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 9, 2026 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 29, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Neuromodulation
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 7000 Central Ave., NE, Minneapolis, MN, 55432
Sources and methodology
- Original FDA record: P970004/S458
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

